GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Despite the importance of interleukin-13 (IL-13) in systemic sclerosis (SSc) and other fibrotic diseases, its mechanisms of action are not understood. We have reported that excessive amounts of IL-13 are produced by peripheral blood effector CD8+ T cells from patients with diffuse cutaneous SSc (dcSSc). The aim of the present study was to establish the molecular basis of IL-13 dysregulation in the pathogenesis of SSc. METHODS: Quantitative polymerase chain reaction analysis and intracellular staining were used to study the transcription factors that control naive peripheral blood CD8+ T cell differentiation into type 1 and type 2 cytokine-secreting cells. Intracellular staining revealed that GATA-3 levels in freshly isolated naive CD8+ T cells correlated with specific clinical manifestations. We therefore assessed the effects of GATA-3 inhibition on IL-13 production in CD8+ T cells from the SSc patients. RESULTS: Freshly isolated naive peripheral blood CD8+ T cells expressed high levels of GATA-3 and failed to down-regulate IL-13 production when cultured under type 1-skewing conditions, but maintained adequate levels of interferon-γ production. Cellular GATA-3 levels were significantly higher in patients with dcSSc and early inflammatory disease. Silencing of GATA-3 with small interfering RNA significantly reduced IL-13 production by CD8+ T cells, demonstrating a causal relationship between GATA-3 and IL-13. CONCLUSION: These results provide important new insights into SSc pathogenesis and suggest that increased GATA-3 expression in CD8+ T cells could be a highly relevant biomarker of immune dysfunction in patients with dcSSc. GATA-3 could be a novel therapeutic target for this currently incurable disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zheng, W.-P., & Flavell, R. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80240-8 · Cited by 2,384
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Distinct Effects of T-bet in T H 1 Lineage Commitment and IFN-γ Production in CD4 and CD8 T Cells
Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P., & Glimcher, L. H. (2002) · Science · doi:10.1126/science.1065543 · Cited by 1,172
Transcriptional regulation of Th1/Th2 polarization
Rengarajan, J., Szabo, S. J., & Glimcher, L. H. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01712-6 · Cited by 433
T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease
Boin, F., De Fanis, U., Bartlett, S. J., Wigley, F. M., Rosen, A., & Casolaro, V. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23406 · Cited by 81
Research works printed but not linked: 45
- Gabrielli, 2009, Scleroderma, N Engl J Med, 360, 1989, 10.1056/NEJMra0806188 · DOI · Paper page
- Medsger, 2003, Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being, Rheum Dis Clin North Am, 29, 255, 10.1016/S0889-857X(03)00023-1 · DOI · Paper page
- LeRoy, 1988, Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis, J Rheumatol, 15, 202
- Gu, 2008, The immunobiology of systemic sclerosis, Semin Arthritis Rheum, 38, 132, 10.1016/j.semarthrit.2007.10.010 · DOI · Paper page
- Varga, 2007, Systemic sclerosis: a prototypic multisystem fibrotic disorder, J Clin Invest, 117, 557, 10.1172/JCI31139 · DOI · Paper page
- Fleischmajer, 1977, Cellular infiltrates in scleroderma skin, Arthritis Rheum, 20, 975, 10.1002/art.1780200410 · DOI · Paper page
- Prescott, 1992, Sequential dermal microvascular and perivascular changes in the development of scleroderma, J Pathol, 166, 255, 10.1002/path.1711660307 · DOI · Paper page
- Roumm, 1984, Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, subtyping, and clinical correlations, Arthritis Rheum, 27, 645, 10.1002/art.1780270607 · DOI · Paper page
- Atamas, 1999, Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis, Arthritis Rheum, 42, 1168, 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L · doi:10.1002/1529-0131(199906)42:6<1168::aid-anr13>3.0.co;2-l
- Chizzolini, 2007, Update on pathophysiology of scleroderma with special reference to immunoinflammatory events, Ann Med, 39, 42, 10.1080/07853890601098152 · DOI
- Whiteside, 1984, Products of activated mononuclear cells modulate accumulation of collagen by normal dermal and scleroderma fibroblasts in culture, J Lab Clin Med, 104, 355
- Fuschiotti, 2009, Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis, Arthritis Rheum, 60, 1119, 10.1002/art.24432 · DOI
- Casciola-Rosen, 1999, Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity, J Exp Med, 190, 815, 10.1084/jem.190.6.815 · DOI · Paper page
- Kahaleh, 1997, Mechanism of serum-mediated endothelial injury in scleroderma: identification of a granular enzyme in scleroderma skin and sera, Clin Immunol Immunopathol, 83, 32, 10.1006/clin.1996.4322 · DOI
- Wills-Karp, 2008, Untangling the complex web of IL-4- and IL-13-mediated signaling pathways, Sci Signal, 1, pe55, 10.1126/scisignal.1.51.pe55 · DOI · Paper page
- Andrew, 1998, STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13, J Immunol, 161, 5027, 10.4049/jimmunol.161.9.5027 · DOI · Paper page
- Aliprantis, 2007, Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13, Proc Natl Acad Sci U S A, 104, 2827, 10.1073/pnas.0700021104 · DOI · Paper page
- Granel, 2006, Evaluation of interleukin 13 polymorphisms in systemic sclerosis, Immunogenetics, 58, 693, 10.1007/s00251-006-0135-0 · DOI
- Granel, 2006, IL13RA2 gene polymorphisms are associated with systemic sclerosis, J Rheumatol, 33, 2015
- Agarwal, 1998, Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation, Immunity, 9, 765, 10.1016/S1074-7613(00)80642-1 · DOI · Paper page
- Kaplan, 1996, Stat6 is required for mediating responses to IL-4 and for development of Th2 cells, Immunity, 4, 313, 10.1016/S1074-7613(00)80439-2 · DOI · Paper page
- Ansel, 2006, Regulation of Th2 differentiation and Il4 locus accessibility, Annu Rev Immunol, 24, 607, 10.1146/annurev.immunol.23.021704.115821 · DOI · Paper page
- Lavenu-Bombled, 2002, Interleukin-13 gene expression is regulated by GATA-3 in T cells: role of a critical association of a GATA and two GATG motifs, J Biol Chem, 277, 18313, 10.1074/jbc.M110013200 · DOI
- Zhou, 2003, The function role of GATA-3 in Th1 and Th2 differentiation, Immunol Res, 28, 25, 10.1385/IR:28:1:25 · DOI
- Kishikawa, 2001, The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3, J Immunol, 167, 4414, 10.4049/jimmunol.167.8.4414 · DOI · Paper page
- Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum, 23, 581, 10.1002/art.1780230510 · DOI · Paper page
- LeRoy, 2001, Criteria for the classification of early systemic sclerosis, J Rheumatol, 28, 1573
- Perera, 2007, Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody, Arthritis Rheum, 56, 2740, 10.1002/art.22747 · DOI
- Clements, 1995, Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis, J Rheumatol, 22, 1281
- Steen, 2005, Autoantibodies in systemic sclerosis, Semin Arthritis Rheum, 35, 35, 10.1016/j.semarthrit.2005.03.005 · DOI · Paper page
- Ho, 2002, Transcription: tantalizing times for T cells, Cell, 109, S109, 10.1016/S0092-8674(02)00705-5 · DOI · Paper page
- Needleman, 1992, Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon-γ levels in sera from patients with scleroderma, Arthritis Rheum, 35, 67, 10.1002/art.1780350111 · DOI · Paper page
- Atamas, 2003, Cytokine regulation of pulmonary fibrosis in scleroderma, Cytokine Growth Factor Rev, 14, 537, 10.1016/S1359-6101(03)00060-1 · DOI
- Constant, 1997, Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches, Annu Rev Immunol, 15, 297, 10.1146/annurev.immunol.15.1.297 · DOI · Paper page
- O'Garra, 1998, Cytokines induce the development of functionally heterogeneous T helper cell subsets, Immunity, 8, 275, 10.1016/S1074-7613(00)80533-6 · DOI · Paper page
- Gourh, 2009, Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines, Arthritis Rheum, 60, 3794, 10.1002/art.24958 · DOI
- Yoshimoto, 2009, Basophils contribute to TH2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells, Nat Immunol, 10, 706, 10.1038/ni.1737 · DOI · Paper page
- Ouyang, 2000, Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment, Immunity, 12, 27, 10.1016/S1074-7613(00)80156-9 · DOI · Paper page
- Finkelman, 2009, Basophils as TH2-inducing APCs: the dog can sing but is it a diva?, Immunol Cell Biol, 87, 568, 10.1038/icb.2009.67 · DOI
- Rankin, 2010, IL-33 induces IL-13-dependent cutaneous fibrosis, J Immunol, 184, 1526, 10.4049/jimmunol.0903306 · DOI · Paper page
- Miyahara, 2004, Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness, Nat Med, 10, 865, 10.1038/nm1081 · DOI · Paper page
- Ray, 1999, Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation, J Clin Invest, 104, 985, 10.1172/JCI8204 · DOI · Paper page
- Nakamura, 1999, Gene expression of the GATA-3 transcription factor is increased in atopic asthma, J Allergy Clin Immunol, 103, 215, 10.1016/S0091-6749(99)70493-8 · DOI · Paper page
- Lee, 2004, Transgenic mice which overproduce Th2 cytokines develop spontaneous atopic dermatitis and asthma, Int Immunol, 16, 1155, 10.1093/intimm/dxh117 · DOI · Paper page
- Cousins, 2008, Therapeutic approaches for control of transcription factors in allergic disease, J Allergy Clin Immunol, 121, 803, 10.1016/j.jaci.2008.02.008 · DOI
Cited by
T cells in systemic sclerosis: a reappraisal
O'Reilly, S., Hugle, T., & van Laar, J. M. (2012) · Rheumatology · doi:10.1093/rheumatology/kes090 · Cited by 218
Strategies targeting the IL-4/IL-13 axes in disease
May, R. D., & Fung, M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.018 · Cited by 166
Nociplastic pain: the prominent role of non-neuronal cells in central and peripheral sensitization
Lai, W., Tang, X., Chen, S., Zhou, Y., Qi, Z., Cao, M., Yuan, C., Yu, J., & Wen, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1677310 · Cited by 5
Metadata
- Authors
- Medsger, T. A., Ivanco, D. E., Kardava, L., Morel, P. A., Lucas, M. R., & Fuschiotti, P.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2011-06
- Volume
- 63
- Issue
- 6
- Pages
- 1738-1747
- ISSN
- 0004-3591 (ISSN-L)
- OpenAlex
- W1966312117
- Cited by
- 53
- References
- 5
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1553 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production. https://app.cochat.ai/papers/10.1002/art.30489
- The paper
- Medsger, T. A., Ivanco, D. E., Kardava, L., Morel, P. A., Lucas, M. R., & Fuschiotti, P. (2011). GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production. Arthritis & Rheumatism. https://doi.org/10.1002/art.30489
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.